Lijuan Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lijuan Zhao has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Li Fan
2 shared publicationsQingwei Zhao
2 shared publicationsSiyu Chen
2 shared publicationsXianhui Cai
2 shared publicationsXiaobo Li
2 shared publications- Jiayi Qin
Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
1 shared publication
Latest Publications
- Open Access
- 6 October 2026
- Published by Elsevier in SSRN Electronic Journal
Total flavonoids from Scutellaria baicalensis restore intestinal barrier function and mucosal hypoxic homeostasis through gut microbiota-dependent bile acid remodeling in type 2 diabetic mice
Ethnopharmacological relevance: Scutellaria baicalensis Georgi (Huangqin) is a traditional Chinese herb for metabolic and gastrointestinal disorders. Our previous studies found that its total flavonoids (STF) and major constituent baicalin lower blood glucose, partly via bile acid regulation. However, how the gut microbiota, bile acids and mucosal homeostasis interact remains unclear.,Aim of the study: To investigate whether STF protects against intestinal barrier injury and disturbed mucosal hypoxia homeostasis in type 2 diabetic (T2DM) mice, and clarify the role of gut microbiota-dependent bile acid remodeling.,Materials and Methods: STF composition was characterized by UPLC-Q-TOF-MS. T2DM was induced by high-fat diet plus streptozotocin (HFD/STZ); another cohort received antibiotics for microbiota depletion. Mice received STF for 4 weeks. Glycolipid metabolism, intestinal barrier, gut microbiota, bile acids, and colonic HIF-1α/IL-22 were assessed. In HIF-1α-silenced hypoxic IEC-6 cells, baicalin and the STF-restored ursodeoxycholic acid (UDCA) were tested for barrier repair.,Results: STF (90.44% baicalin) ameliorated hyperglycemia, insulin resistance, and dyslipidemia, and restored intestinal barrier integrity (occludin, ZO-1, MUC2). STF remodeled microbiota dysbiosis and bile acid homeostasis. It restored colonic physiological hypoxia, lowered pathologically elevated HIF-1α, and raised IL-22 in RORγt⁺ cells. These benefits were abrogated in microbiota-depleted mice. In vitro, HIF-1α silencing abrogated the barrier-repairing effects of baicalin and UDCA.,Conclusions: Gut microbiota-dependent bile acid remodeling contributes to STF-mediated restoration of the intestinal barrier and mucosal hypoxia homeostasis in T2DM mice. These findings support the ethnomedical use of S. baicalensis in diabetic intestinal complications and highlight the gut microbiota–bile acid axis as a therapeutic target.
- 6 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessTotal flavonoids from Scutellaria baicalensis restore intestinal barrier function and mucosal hypoxic homeostasis through gut microbiota-dependent bile acid remodeling in type 2 diabetic mice
Ethnopharmacological relevance: Scutellaria baicalensis Georgi (Huangqin) is a traditional Chinese herb for metabolic and gastrointestinal disorders. Our previous studies found that its total flavonoids (STF) and major constituent baicalin lower blood glucose, partly via bile acid regulation. However, how the gut microbiota, bile acids and mucosal homeostasis interact remains unclear.,Aim of the study: To investigate whether STF protects against intestinal barrier injury and disturbed mucosal hypoxia homeostasis in type 2 diabetic (T2DM) mice, and clarify the role of gut microbiota-dependent bile acid remodeling.,Materials and Methods: STF composition was characterized by UPLC-Q-TOF-MS. T2DM was induced by high-fat diet plus streptozotocin (HFD/STZ); another cohort received antibiotics for microbiota depletion. Mice received STF for 4 weeks. Glycolipid metabolism, intestinal barrier, gut microbiota, bile acids, and colonic HIF-1α/IL-22 were assessed. In HIF-1α-silenced hypoxic IEC-6 cells, baicalin and the STF-restored ursodeoxycholic acid (UDCA) were tested for barrier repair.,Results: STF (90.44% baicalin) ameliorated hyperglycemia, insulin resistance, and dyslipidemia, and restored intestinal barrier integrity (occludin, ZO-1, MUC2). STF remodeled microbiota dysbiosis and bile acid homeostasis. It restored colonic physiological hypoxia, lowered pathologically elevated HIF-1α, and raised IL-22 in RORγt⁺ cells. These benefits were abrogated in microbiota-depleted mice. In vitro, HIF-1α silencing abrogated the barrier-repairing effects of baicalin and UDCA.,Conclusions: Gut microbiota-dependent bile acid remodeling contributes to STF-mediated restoration of the intestinal barrier and mucosal hypoxia homeostasis in T2DM mice. These findings support the ethnomedical use of S. baicalensis in diabetic intestinal complications and highlight the gut microbiota–bile acid axis as a therapeutic target.
- Open Access
- 29 June 2026
- Published by Elsevier in SSRN Electronic Journal
Scutellaria baicalensis flavonoids repair intestinal barrier damage in type 2 diabetic mice via gut microbiota–bile acid–ILC3/IL-22 signaling network mediated by HIF-1α
Background: Intestinal barrier dysfunction plays a critical role in the pathogenesis of type 2 diabetes mellitus (T2DM). The total flavonoids of Scutellaria baicalensis flavonoids (STF) have been used to manage diabetic conditions, however, their specific effects on intestinal barrier repair and the underlying mechanisms remain elusive.Purpose: To investigate whether STF repairs intestinal barrier damage in T2DM via the gut microbiota–bile acid–ILC3/IL-22 signaling network mediated by HIF-1α.Methods: A T2DM mouse model was established using a high-fat diet combined with streptozotocin injection. The composition of STF was analyzed by UPLC-Q-TOF-MS. Pharmacodynamic effects, 16S rRNA sequencing, serum metabolomics, and targeted bile acid metabolomics were evaluated. Antibiotic-induced microbiota-depleted mice and HIF-1α-silenced IEC-6 cells were employed to determine causality and elucidate the molecular mechanism.Results: STF, comprising 90.44% baicalin, significantly ameliorated hyperglycemia, insulin resistance, dyslipidaemia, and organ damage in T2DM mice. Notably, STF restored intestinal barrier integrity, as evidenced by improved mucosal architecture, upregulated expression of tight junction proteins (occludin, ZO-1, MUC2), and reduced intestinal permeability. Moreover, STF modulated gut microbiota by remodeling the dysregulated microbial composition and restoring disrupted bile acid homeostasis. Mechanistically, STF restored impaired intestinal physiological hypoxia, downregulated HIF-1α expression, and enhanced ILC3-derived IL-22 production. These effects were abrogated in microbiota-depleted mice. In vitro, baicalin and UDCA (a bile acid species restored by STF) promoted barrier repair under hypoxia conditions, which was abolished by HIF-1α silencing.Conclusion: This study provides novel evidence that STF repairs intestinal barrier damage in T2DM through a gut microbiota-dependent mechanism involving bile acid metabolism and HIF-1α-mediated ILC3/IL-22 activation, These findings support the clinical application of S. baicalensis in diabetes management.
- 29 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessScutellaria baicalensis flavonoids repair intestinal barrier damage in type 2 diabetic mice via gut microbiota–bile acid–ILC3/IL-22 signaling network mediated by HIF-1α
Background: Intestinal barrier dysfunction plays a critical role in the pathogenesis of type 2 diabetes mellitus (T2DM). The total flavonoids of Scutellaria baicalensis flavonoids (STF) have been used to manage diabetic conditions, however, their specific effects on intestinal barrier repair and the underlying mechanisms remain elusive.Purpose: To investigate whether STF repairs intestinal barrier damage in T2DM via the gut microbiota–bile acid–ILC3/IL-22 signaling network mediated by HIF-1α.Methods: A T2DM mouse model was established using a high-fat diet combined with streptozotocin injection. The composition of STF was analyzed by UPLC-Q-TOF-MS. Pharmacodynamic effects, 16S rRNA sequencing, serum metabolomics, and targeted bile acid metabolomics were evaluated. Antibiotic-induced microbiota-depleted mice and HIF-1α-silenced IEC-6 cells were employed to determine causality and elucidate the molecular mechanism.Results: STF, comprising 90.44% baicalin, significantly ameliorated hyperglycemia, insulin resistance, dyslipidaemia, and organ damage in T2DM mice. Notably, STF restored intestinal barrier integrity, as evidenced by improved mucosal architecture, upregulated expression of tight junction proteins (occludin, ZO-1, MUC2), and reduced intestinal permeability. Moreover, STF modulated gut microbiota by remodeling the dysregulated microbial composition and restoring disrupted bile acid homeostasis. Mechanistically, STF restored impaired intestinal physiological hypoxia, downregulated HIF-1α expression, and enhanced ILC3-derived IL-22 production. These effects were abrogated in microbiota-depleted mice. In vitro, baicalin and UDCA (a bile acid species restored by STF) promoted barrier repair under hypoxia conditions, which was abolished by HIF-1α silencing.Conclusion: This study provides novel evidence that STF repairs intestinal barrier damage in T2DM through a gut microbiota-dependent mechanism involving bile acid metabolism and HIF-1α-mediated ILC3/IL-22 activation, These findings support the clinical application of S. baicalensis in diabetes management.
- Open Access
- 21 July 2025
- Published by Zhejiang University Press in Bio-Design and Manufacturing
- Vol. 8 (4) , 609-624
Homologous cancer cell membrane-camouflaged natural pH-sensitive chalk for enhanced drug targeting delivery in hepatocellular carcinoma
The therapeutic efficacy of hepatocellular carcinoma (HCC) medication is severely compromised by inadequate drug delivery to tumor sites. Herein, we fabric
- 21 July 2025
- Published by Zhejiang University Press in Bio-Design and Manufacturing
- Vol. 8 (4) , 609-624
Open AccessHomologous cancer cell membrane-camouflaged natural pH-sensitive chalk for enhanced drug targeting delivery in hepatocellular carcinoma
The therapeutic efficacy of hepatocellular carcinoma (HCC) medication is severely compromised by inadequate drug delivery to tumor sites. Herein, we fabric